Taro Pharmaceutical
TARO
$42.19
Share price
-0.26%
Change (1 day)
46.14%
Change (1 year)
Categories
Market capitalization of Taro Pharmaceutical (TARO)
Market cap: $1.58 Billion
As of May 2024 Taro Pharmaceutical has a market cap of $1.58 Billion. This makes Taro Pharmaceutical the world's 4518th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Taro Pharmaceutical from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.58 B | 0.98% |
| 2023 | $1.57 B | 43.87% |
| 2022 | $1.09 B | -42.05% |
| 2021 | $1.88 B | -32.95% |
| 2020 | $2.80 B | -17.11% |
| 2019 | $3.38 B | 2.61% |
| 2018 | $3.30 B | -21.35% |
| 2017 | $4.19 B | -2.79% |
| 2016 | $4.31 B | -34.75% |
| 2015 | $6.61 B | 4.29% |
| 2014 | $6.34 B | 43.36% |
| 2013 | $4.42 B | 105.34% |
| 2012 | $2.15 B | 64.12% |
| 2011 | $1.31 B | 110.47% |
| 2010 | $0.62 B | 79.1% |
| 2009 | $0.34 B | 15.47% |
| 2008 | $0.30 B | 0.01% |
| 2007 | $0.30 B | 2.8% |
| 2006 | $0.29 B | -28.28% |
| 2005 | $0.40 B | -58.76% |
| 2004 | $0.99 B | -46.87% |
| 2003 | $1.86 B | 72.88% |
| 2002 | $1.08 B | 2.86% |
| 2001 | $1.05 B |
End of Day market cap according to different sources
On May 13th, 2024 the market cap of Taro Pharmaceutical was reported to be:
$1.58 Billion
$1.58 Billion
$1.58 Billion
$1.58 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $363.93 B | 22,851.35% | 🇺🇸 USA |
 Novartis NVS | $209.47 B | 13,110.21% | 🇨🇭 Switzerland |
 Pfizer PFE | $161.15 B | 10,063.23% | 🇺🇸 USA |
 Merck MRK | $327.46 B | 20,551.33% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $93.41 B | 5,791.32% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $19.11 B | 1,105.72% | 🇮🇱 Israel |